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Abstract Protein kinase C (PKC) has been suggested to
mediate, at least in part, multiple processes in the pathophysio-
logical sequelae of myocardial ischemia. The present study
demonstrates that the O, R and S isozymes of PKC are
translocated to nuclei in response to brief intervals of global
ischemia as well as reperfusion of ischemic rat myocardium.
Concomitant with the translocation of PKC isozymes to nuclei
during ischemia, increased PKC-mediated nuclear protein
phosphorylation was observed. Taken together, the present
results demonstrate that nuclear signaling mechanisms are
activated during myocardial ischemia that include PKC translo-
cation and PKC-mediated nuclear protein phosphorylation.
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1. Introduction
Protein kinase C (PKC) is a ubiquitous enzyme that is in-
volved in signal transduction pathways resulting in cell pro-
liferation and di¡erentiation [1^4]. In the heart, PKC is be-
lieved to play a role in ischemic preconditioning by a
mechanism involving modulation of KATP channel activity
[5^8]. In addition to the putative role of PKC in myocardial
ischemic preconditioning, PKC may play an important role in
the pathophysiological sequelae of myocardial ischemia in-
cluding arrhythmogenesis and long-term myocardial dysfunc-
tion following recovery from ischemia. This latter e¡ect medi-
ated by PKC likely is coupled to the MAP kinase cascade and
the activation of proto-oncogenes [9^11].
Several PKC isozymes, including the K, O and R isozymes,
have been shown to translocate to crude particulate fractions
during myocardial ischemia [12,13]. However, the identi¢ca-
tion of the subcellular membrane pools that are enriched with
speci¢c PKC isozymes during myocardial ischemia is only
partially known [14]. Additionally, although activated PKC
has been detected in crude particulate fractions prepared
from ischemic myocardium [15,16], the activation of PKC in
speci¢c subcellular membrane pools has not been determined
in ischemic myocardium. Taken together, the subcellular
membrane target(s) of activated PKC during myocardial is-
chemia is not clear.
Since it is likely that activated nuclear PKC isozymes have
profound e¡ects on post-ischemic myocardial function, the
present studies were designed to determine the PKC isozymes
that are translocated to nuclei during myocardial ischemia.
The results herein demonstrate that during global myocardial
ischemia the O, R and S isozymes of PKC translocate to the
nucleus. Concomitant with increases in PKC isozymes trans-
located to the nuclei, nuclear protein phosphorylation in-
creased during myocardial ischemia, which collectively dem-
onstrate accelerated nuclear signaling during myocardial
ischemia.
2. Materials and methods
2.1. Preparation of Langendor¡-perfused rat hearts and induction of
myocardial ischemia and reperfusion
Male Sprague-Dawley rats (200^250 g body weight) were injected
with heparin (200 U i.p.) 30 min before being anesthetized with pen-
tobarbital (25 mg i.p.) and the hearts were subsequently removed and
placed in ice-cold saline prior to being perfused. Rat hearts were
perfused retrogradely via the aorta (Langendor¡-perfused) with modi-
¢ed Krebs-Henseleit bu¡er consisting of 137 mM NaCl, 4.7 mM KCl,
3 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 0.5 mM NaEDTA,
15 mM NaHCO3, and 11 mM glucose equilibrated with O2/CO2 (95/
5) (pH = 7.4) at 37‡C for 15 min at a constant aortic perfusion pres-
sure of 60 mm Hg. In selected experiments, hearts were pulse-chase
radiolabeled with 32Pi prior to experimental conditions. In brief,
hearts were perfused for 45 min in a recirculating bu¡er mode with
modi¢ed Krebs-Henseleit bu¡er that contained only 120 WM KH2PO4
as well as 625 WCi (9 Ci/Wmol) of 32Pi. Following 32Pi labeling, hearts
were perfused with modi¢ed Krebs-Henseleit bu¡er containing 1.2 mM
KH2PO4 for 15 min in a non-recirculating mode. In indicated experi-
ments, 50 nM bisindolylmaleimide I (BIM I) was included in the
perfusion bu¡er during the last 5 min of the 15 min chase interval.
Following these perfusion protocols, Langendor¡-perfused hearts
were either control-perfused at 60 mm Hg (control), rendered globally
ischemic for indicated intervals, or rendered globally ischemic for
indicated intervals followed by reperfusion for indicated intervals as
previously described [17]. At the end of each perfusion interval, ven-
tricles were either rapidly freeze-clamped or directly homogenized for
the preparation of cytosol and particulate or nuclei, respectively (see
below).
2.2. Preparation of cytosolic, particulate and nuclear fractions from
isolated perfused hearts
For the preparation of cytosolic and particulate fractions, freeze-
clamped ventricular tissue was pulverized to a ¢ne powder at the
temperature of liquid nitrogen. Myocardial tissue (V0.8 gwetweight)
was then homogenized at 4‡C in 20 ml of homogenization bu¡er A
(20 mM Tris-HCl, 0.33 M sucrose, 5 mM EDTA, 0.5 mM EGTA,
1 mM PMSF and 0.005% leupeptin; pH = 7.4) utilizing a polytron
(50% setting for 20 s) followed by Potter-Elvehjem homogenization
with 5 strokes at a setting of 50%. Homogenates were then centrifuged
at 24 000Ugmax for 20 min to collect cytosolic (supernatant) and par-
ticulate (pellet) fractions.
Rat heart nuclei were prepared as previously described with all
steps maintained at 4‡C [18]. In brief, ventricles from perfused hearts
were immediately minced in 10 volumes of homogenization bu¡er B
(10 mM Tris-HCl, 250 mM sucrose, 3 mM MgCl2 and 0.1 mM
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PMSF; pH = 7.4) following experimental conditions and then homo-
genized utilizing a polytron (40% setting for 10 s). The homogenate
was then centrifuged at 1000Ugmax for 10 min and the pellet was
subsequently resuspended in 10 volumes of homogenization bu¡er
and re-homogenized with a Potter-Elvehjem homogenizer. The homo-
genate of the 1000Ugmax pellet was ¢ltered through nylon sieve mesh
(100 Wm) and the ¢ltrate was then centrifuged at 1000Ugmax for
10 min. The resultant pellet was resuspended in 10 volumes of ho-
mogenization bu¡er B supplemented with 0.1% Triton X-100. Again,
the resuspended pellet was centrifuged at 1000Ugmax for 10 min and
subsequently the pellet was resuspended in 20 volumes of homogeni-
zation bu¡er B adjusted to 2.2 M sucrose. The resuspended pellet in
sucrose was then underlaid with 5 ml of homogenization bu¡er B
containing 2.2 M sucrose and then subjected to ultracentrifugation
in a swinging bucket rotor (SW-28) at 113 000Ugmax for 1 h. The
pellet (nuclei) was resuspended in homogenization bu¡er B without
sucrose and immediately used for gel electrophoresis. The purity of
the nuclear preparations was ascertained by immunoblotting with
anti-lamin B1 (Zymed) which demonstrated the enrichment of lamin
B1 in the nuclear preparations as compared to that of the cytosol and
crude particulate.
2.3. Western blot analysis of PKC isozymes from subcellular fractions
prepared from isolated perfused rat hearts
Cytosolic, nucleus-associated, and particulate-associated proteins
prepared from isolated perfused rat hearts were quantitated by either
a Bio-Rad protein assay or Lowry protein assay [19] and subsequently
the samples were adjusted to equal protein concentrations prior to
being subjected to SDS-PAGE in the presence of DTT utilizing 10%
polyacrylamide gels (10 Wg protein loaded per lane) with the exception
that samples were subjected to SDS-PAGE in the absence of DTT for
analysis of the SERCA2 ATPase and troponin I (TnI). Proteins were
then quantitatively transferred to PVDF-plus membranes (Micron
Separations Inc., Westborough, MA). The membranes were sequen-
tially blocked for 1 h with 5% dry milk in Tris-bu¡ered saline
(pH = 7.6) at room temperature and then incubated for 1 h with pri-
mary antibodies at indicated concentrations in 5% dry milk in Tris-
bu¡ered saline (pH = 7.6) containing 0.05% Tween 20. It should be
noted that each of these primary antibodies was determined to be
isozyme-speci¢c when screened for reactivity with recombinant human
PKC isozymes. Next the membranes were washed with Tris-bu¡ered
saline containing 0.1% Tween 20 and then incubated 1 h with the
appropriate horseradish peroxidase-conjugated secondary antibodies
(Sigma goat anti-rabbit HRP, 1/7000 dilution or Bio-Rad goat anti-
mouse HRP, 1/7000 dilution) in Tris-bu¡ered saline containing 0.1%
Tween 20 at room temperature at indicated concentrations. Immuno-
reactive bands were then visualized by chemiluminescence detected on
X-ray ¢lm (Kodak X-OMAT AR) utilizing the ECL chemilumines-
cence system (Amersham Corp.). Multiple exposures of ¢lm to the
blots were developed. Exposures that had linear levels of grain devel-
opment were used for quantitation of band intensity utilizing NIH
Image software following scanning and conversion of autoradio-
graphic data to TIFF ¢le formats using a Macintosh 5500/225 com-
puter and a Linocolor-Hell Jade scanner. Quantitative analysis of the
autoradiographic data was performed using the public domain NIH
Image program (developed at the U.S. National Institutes of Health
and available on the Internet at http://rsb.info.nih.gov/nih-image/). In
all cases, the use of control peptides to these isozyme-speci¢c PKC
antibodies resulted in the loss of the PKC isozyme signal in Western
blots.
2.4. Silver staining and autoradiography of SDS-PAGE gels
To ensure that both equal amounts of protein were loaded onto gels
utilized for autoradiography and Western blot analysis and that sub-
cellular fractions prepared from control and ischemic myocardium
were similar in their individual protein pro¢les, parallel SDS-PAGE
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Fig. 1. The translocation of the O, R and S isozymes of PKC to nuclei during myocardial ischemia and reperfusion. Isolated adult rat hearts
were Langendor¡-perfused for 15 min with modi¢ed Krebs-Henseleit bu¡er and were subsequently subjected to either 20 min of perfusion (C,
control), 5 min of global ischemia (5I), 10 min of global ischemia (10I), 20 min of global ischemia (20I), 5 min of global ischemia followed by
15 min of reperfusion (5IR) or 20 min of global ischemia followed by 15 min of reperfusion (20IR). Following each experimental interval, nu-
clei were prepared from ventricular tissue and nuclear proteins from each heart were then subjected to sequential SDS-PAGE and Western blot
analysis as described in Section 2. Representative Western blots are shown in A. Blots (A) were probed with either anti-O PKC (Sigma; rabbit,
4 Wl/10 ml), anti-R PKC (Santa Cruz; rabbit, 5 Wl/10 ml), anti-S PKC (Transduction Laboratories; mouse, 20 Wl/10 ml), anti-K PKC (Sigma;
rabbit, 1 Wl/10 ml), or anti-lamin B1 (Zymed; rabbit, 5 Wl/10 ml) as the primary antibodies. Positive controls (Pos. C.) on blots were the appro-
priate human recombinant PKC isozyme for O, R, and K isozymes or rat brain lysate for the S isozyme. The intensity of each band from each
individual blot was quantitated utilizing NIH Image software and expressed as a percentage of the intensity of the control sample on each indi-
vidual blot as described in Section 2 (B). Values for B are the means+S.E.M. from at least three individual independent experiments. *P6 0.05
and **P6 0.01, for comparisons between the indicated condition and the control condition.
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gels were prepared and subsequently silver stained utilizing the Bio-
Rad Silver Stain Plus kit. In experiments utilizing nuclei that were 32Pi
labeled, proteins were subjected to gel electrophoresis followed by
autoradiography utilizing X-ray ¢lm (Kodak X-OMAT AR). Multiple
exposures of ¢lm to the blots were developed.
2.5. Materials
Anti-K, -LI, -LII, -Q and -O PKC were from Sigma. Anti-R and -j
PKC were purchased from Santa Cruz. Anti-S PKC was purchased
from Transduction Laboratories. Anti-Na/K ATPase L-1 and anti-
SERCA2 ATPase were obtained from UBI and A⁄nity Bioreagents,
respectively. Anti-TnI was purchased from Chemicon International.
Secondary antibodies including goat anti-rabbit horseradish peroxi-
dase and goat anti-mouse horseradish peroxidase were purchased
from Sigma or Bio-Rad. Electrophoresis grade reagents for gel elec-
trophoresis were purchased from ICN, Pharmacia and Bio-Rad. All
other chemicals were purchased from either Sigma or Fisher. 32Pi was
purchased from NEN DuPont.
3. Results
3.1. Identi¢cation of the translocation of speci¢c PKC isozymes
to the nucleus during myocardial ischemia and reperfusion
in the isolated perfused adult rat heart
Since it is likely that activated nuclear PKC isozymes have
profound e¡ects on post-ischemic myocardial function, ex-
periments were performed to test the hypothesis that speci¢c
PKC isozymes are translocated to the nucleus during myocar-
dial ischemia and ischemia-reperfusion protocols. Utilizing the
isolated perfused rat heart model, 10 min of global ischemia
resulted in signi¢cant increases in the levels of the O, R and S
PKC isozymes associated with the nucleus which increased
further with prolonged global ischemia (e.g. 20 min of global
ischemia) and was maintained at an increased level in hearts
subjected to 20 min of global ischemia followed by 15 min of
reperfusion (Fig. 1). In addition, the S isozyme of PKC was
translocated to the nucleus within 5 min of global ischemia (5I
in Fig. 1) while the O and R isozymes of PKC were not sig-
ni¢cantly translocated to the nucleus following 5 min of is-
chemia. Also, the O, R and S isozymes of PKC were not
present in the nucleus following 5 min of ischemia with sub-
sequent reperfusion for 15 min (5IR) (Fig. 1). The presence of
nuclei in the fractions used for these blots was con¢rmed by
Western blotting utilizing anti-lamin B1 (Fig. 1). It should
also be noted that although the K PKC isozyme (Fig. 1)
was also present in rat heart nuclei, the distribution of this
isozyme was not altered following myocardial ischemia or
ischemia followed by reperfusion. Additionally, the LI, LII,
Q and j PKC isozymes were not detected in the nuclear prep-
arations from the adult rat heart (data not shown). Concom-
itant with the increases in nucleus-associated PKC during 20
min of global ischemia, decreases in cytosolic O and S PKC
isozymes were observed (Fig. 2). Additionally, the K, O and S
PKC isozymes were translocated to the particulate fraction
following 20 min of global ischemia (Fig. 2). It should be
appreciated that in contrast to the O, R and S PKC isozymes,
the K isozyme of PKC was translocated to crude particulate
but was not translocated to the nucleus during global ischemia
(Fig. 2). Furthermore, although the R PKC isozyme was
translocated to the nuclei of ischemic hearts, this isozyme
was not spatially translocated between the cytosol and partic-
ulate fractions in response to ischemia and was preferentially
localized in the crude particulate fraction prepared from both
control and ischemic hearts (Fig. 2).
3.2. Enzyme markers of nuclear and particulate fractions
Enzyme marker analysis was performed to demonstrate the
purity of the nuclear preparation used to determine the trans-
location of PKC isozymes to the nucleus during myocardial
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Fig. 2. Western blot analysis of PKC isozymes in cytosol, particulate and nuclei prepared from control and ischemic hearts. Isolated adult rat
hearts were Langendor¡-perfused for 15 min with modi¢ed Krebs-Henseleit bu¡er and were subsequently subjected to either 20 min of perfu-
sion (C, control) or 20 min of global ischemia (20I) as described in Section 2. The indicated cytosolic and particulate fractions as well as nuclei
were prepared and were sequentially subjected to SDS-PAGE and Western blot analysis as described in detail in MSection 2. In A, blots were
probed with either anti-O PKC (Sigma; rabbit, 4 Wl/10 ml), anti-R PKC (Santa Cruz; rabbit, 5 Wl/10 ml), anti-S PKC (Transduction Laborato-
ries; mouse, 20 Wl/10 ml) or anti-K PKC (Sigma; rabbit, 1 Wl/10 ml) as the primary antibodies as described in Section 2. The intensity of each
band from each individual blot was quantitated utilizing NIH Image software and expressed as a percentage of the intensity of the control
sample on each individual blot as described in Section 2 (B). Values for B are the means+S.E.M. from at least three individual independent
experiments.
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ischemia. Fig. 3 documents the purity of the nuclear prepara-
tion used in these studies since the cardiac sarcolemmal
marker, Na/K ATPase L-1 subunit, and the cardiac sarco-
plasmic reticulum marker, SERCA2 ATPase, were only found
in the crude particulate while the nuclear marker, lamin B1,
was highly enriched in the nuclear preparation. Furthermore,
the nuclear preparation was not contaminated with the myo-
¢brillar protein TnI (Fig. 3).
3.3. PKC-mediated protein phosphorylation during myocardial
ischemia
To determine that the translocation of PKC isozymes to the
nucleus during myocardial ischemia results in PKC-mediated
phosphorylation of nuclear proteins, isolated perfused hearts
were prelabeled with 32Pi and then subjected to control perfu-
sions and selected intervals of global ischemia with or without
subsequent reperfusion. The autoradiogram of phosphory-
lated proteins from nuclei isolated from perfused hearts
shown in Fig. 4A demonstrates that protein phosphorylation
is increased following 20 min of global ischemia. In particular,
a V20 kDa protein was extensively phosphorylated in re-
sponse to 20 min of global ischemia (20I) as well as 20 min
of global ischemia followed by 15 min of reperfusion (20IR).
Additionally, during reperfusion a V28 kDa protein was ex-
tensively phosphorylated (Fig. 4A) which likely re£ects di¡er-
ent signaling mechanisms in the reperfused ischemic heart as
compared to that in the ischemic heart (e.g. di¡erences in the
accumulation of speci¢c PKC activators). Furthermore, the
demonstration that nucleus-associated protein phosphoryla-
tion during 20 min of global ischemia was inhibited by treat-
ing hearts with the selective PKC inhibitor, BIM I (50 nM),
prior to ischemia or control perfusions, suggests that the pro-
tein phosphorylation observed during ischemia is mediated by
PKC (Fig. 4A). The addition of BIM I did not appreciably
alter the translocation of the O, R and S PKC isozymes to the
nucleus during global ischemia or ischemia followed by reper-
fusion (data not shown). In parallel experiments, nuclear
preparations that were analyzed by autoradiography in Fig.
4A were also subjected to SDS-PAGE and subsequent silver
staining to ensure that each nuclear preparation contained
equal amounts of protein as well as similar protein composi-
tion (Fig. 4B). Taken together, these data support the hypoth-
esis that PKC isozymes that are translocated to the nucleus
during myocardial ischemia are active and mediate the phos-
phorylation of nuclear proteins.
4. Discussion
PKC has been suggested to mediate, at least in part, multi-
ple processes in the pathophysiological sequelae of myocardial
ischemia including preconditioning, arrhythmogenesis and
long-term dysfunction [5^7,9^11,20]. Despite the potential im-
portance of PKC in the myocardial response to ischemia, the
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Fig. 4. PKC-mediated protein phosphorylation during myocardial ischemia. Isolated perfused hearts were pulse-chase radiolabeled with 32Pi
and subsequently subjected to either 20 min of perfusion (C, control), 5 min of global ischemia (5I), 20 min of global ischemia (20I) or 20 min
of global ischemia followed by 15 min of reperfusion (20IR) in the presence (+BIM I) or absence (3BIM I) of the PKC inhibitor, BIM I
(50 nM). Following each experimental interval, nuclei were prepared from ventricular tissue as described in Section 2 except that 50 mM NaF
and 0.2 mM Na3VO4 were added to bu¡ers. Puri¢ed nuclei were sequentially subjected to SDS-PAGE (10% gel) followed by either autoradiog-
raphy (A) or silver staining (B) as described in Section 2.
Fig. 3. Western blot analysis of subcellular markers in cytosol, par-
ticulate and nuclei prepared from control and ischemic hearts. Iso-
lated adult rat hearts were Langendor¡-perfused for 15 min with
modi¢ed Krebs-Henseleit bu¡er and were subsequently subjected to
either 20 min of perfusion (C, control) or 20 min of global ischemia
(20I) as described in Section 2. The indicated cytosolic and particu-
late fractions as well as nuclei were prepared and were sequentially
subjected to SDS-PAGE and Western blot analysis as described in
detail in Section 2. Blots were probed with either anti-Na/K AT-
Pase L-1 (UBI; mouse, 9 Wl/10 ml), anti-SERCA2 ATPase (A⁄nity
Bioreagents; mouse, 5 Wl/10 ml), anti-lamin B1 (Zymed; mouse, 5 Wl/
10 ml) or anti-TnI (Chemicon International, mouse, 2.5 Wl/10 ml) as
the primary antibodies.
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subcellular localization of PKC isozymes during myocardial
ischemia is not clear. In particular, the long-term responses of
ischemic injury that could be a result of nuclear signaling
involving PKC, have not been delineated. Accordingly, in
the present studies the translocation and activation of PKC
were determined at the nuclear subcellular level. The results
herein demonstrate the selective translocation of the O, R and S
PKC isozymes to the nucleus during global ischemia which is
accompanied by accelerated PKC-mediated nuclear protein
phosphorylation. Furthermore, reperfusion of ischemic hearts
subjected to short intervals of ischemia (e.g. 5 min) resulted in
the reversal of ischemia-induced PKC translocation to the
nucleus. However, reperfusion did not reverse ischemia-in-
duced PKC translocation to the nucleus in hearts subjected
to prolonged ischemia (20 min) which results in irreversible
myocardial damage (e.g. [21]).
Previous studies have demonstrated that the O PKC isozyme
is translocated to the nucleus in response to opiate stimulation
[22]. The O and R PKC isozymes have also been shown to
translocate to crude particulate following global ischemia in
the rabbit heart [13]. In contrast, the S PKC isozyme has not
been shown to translocate in the ischemic heart, although it
has been detected in adult rabbit heart [13] and immature rat
heart [23]. The present ¢ndings now demonstrate that the S
PKC isozyme is translocated to the nuclei during global ische-
mia in the adult rat heart. Since PKC isozymes do not possess
a nuclear localization signal [24], it will be important to de-
termine the biochemical mechanism responsible for the trans-
location of speci¢c PKC isozymes to the nucleus during myo-
cardial ischemia. It is likely that more than one mechanism is
responsible for the translocation of these isozymes to the nu-
cleus during ischemia since the S PKC isozyme, unlike the O
and R PKC isozymes, does not possess a phorbol ester/diac-
ylglycerol binding site [25].
The gross changes in the nuclear protein phosphorylation
state during myocardial ischemia were striking and based on
inhibition by the selective PKC inhibitor, BIM I, it appears
that this protein phosphorylation is mediated by PKC. It
should be noted that it is unlikely that the e¡ects of this
inhibitor are due to the inhibition of cAMP-dependent protein
kinase since the concentration of BIM I employed in this
study is 40-fold less than the Ki of cAMP-dependent protein
kinase [26]. Importantly, the results herein demonstrate that
the translocation of PKC to the nucleus during myocardial
ischemia is accompanied by enhanced PKC-mediated phos-
phorylation of nuclear proteins. Accordingly, it will be impor-
tant to identify the proteins which are phosphorylated by
PKC during ischemia to thoroughly understand the role of
PKC in the pathophysiological sequelae of myocardial ische-
mia.
Taken together, speci¢c PKC isozymes are translocated to
the nucleus during global myocardial ischemia resulting in the
phosphorylation of nuclear proteins. The precise role of each
of these PKC isozymes that are translocated during ischemia,
as well as their protein substrates, remains to be resolved, but
it is likely that one or more of these translocated isozymes and
protein substrates are involved in the pathophysiological se-
quelae of myocardial ischemia. Furthermore, the delineation
of the biochemical mechanism responsible for the transloca-
tion of each of these PKC isozymes to the nucleus during
ischemia should provide new insights into the mechanism of
PKC translocation and activation that could potentially lead
to the development of novel mechanism-based inhibitors.
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